Yüklüyor......
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Advances in the understanding of cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer treatment. Recent large-scale phase III trials (e.g. PHOCUS, OPTiM) are establishing use of oncolytic viruses as another tool in the c...
Kaydedildi:
| Yayımlandı: | Clin Transl Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Berlin Heidelberg
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234197/ https://ncbi.nlm.nih.gov/pubmed/30426287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0214-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|